Belatacept and Risk of Post-transplant Lymphoproliferative Disorder in US Renal Transplant Recipients
Clinical trial NCT01656343 · COMPLETED
Trial details
- NCT number
- NCT01656343
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-10-31
- Primary completion
- 2019-08-05
- Enrollment
- 775
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.